Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)

SHA:605033 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	168.56	267.86	481.17	318.25	254.39	199.41
Short-Term Investments	-	-	-	1.5	-	-
Trading Asset Securities	235.82	388.47	-	79.93	148	-
Cash & Short-Term Investments	404.38	656.33	481.17	399.68	402.39	199.41
Cash Growth	18.13%	36.40%	20.39%	-0.67%	101.79%	-9.25%
Accounts Receivable	258.67	77.16	148.68	189.08	92.49	25.84
Other Receivables	22.24	12.29	10.52	35.69	2.04	2.4
Receivables	280.91	89.45	159.2	224.77	94.53	28.24
Inventory	149.75	264.71	353.7	457.29	559.56	277.97
Prepaid Expenses	-	-	-	14.09	-	-
Other Current Assets	81.25	86.22	77.73	92.58	136.3	100.55
Total Current Assets	916.29	1,097	1,072	1,188	1,193	606.16
Property, Plant & Equipment	657.14	613.67	457.07	185.84	115.72	96.13
Other Intangible Assets	116.59	118.48	83.23	12.27	7.7	7.94
Long-Term Deferred Tax Assets	15.72	15.7	16.43	12.42	4.26	3.31
Long-Term Deferred Charges	0.43	0.54	0.42	0.76	0.97	-
Other Long-Term Assets	35.75	16.93	63.05	160.79	141.94	72.33
Total Assets	1,742	1,862	1,692	1,560	1,463	785.87
Accounts Payable	223.53	305.84	171.77	102.68	130.52	84.03
Accrued Expenses	42.83	48.13	50.06	75.87	44.23	20.25
Short-Term Debt	-	-	1	-	27.05	-
Current Portion of Long-Term Debt	3	1.08	-	-	-	-
Current Income Taxes Payable	0.39	0.44	1.77	2.85	5.55	1
Current Unearned Revenue	38.5	252.07	227.97	151.4	219.24	195.5
Other Current Liabilities	7.59	8.7	8.34	36.93	10.48	9.94
Total Current Liabilities	315.84	616.26	460.91	369.72	437.07	310.73
Long-Term Debt	137	72	-	-	-	-
Long-Term Unearned Revenue	3.12	3.25	1.2	0.78	0.87	-
Long-Term Deferred Tax Liabilities	4.73	4.61	4.78	5.63	5.42	4.33
Other Long-Term Liabilities	133.97	41.26	110.96	98.02	53.08	21.44
Total Liabilities	594.65	737.37	577.84	474.14	496.43	336.5
Common Stock	135.2	135.2	135.2	137.79	135.2	101.4
Additional Paid-In Capital	459.37	459.37	459.37	482.34	459.37	101.33
Retained Earnings	552.71	530.09	519.6	491.78	372.38	246.64
Treasury Stock	-	-	-	-25.57	-	-
Shareholders' Equity	1,147	1,125	1,114	1,086	966.95	449.37
Total Liabilities & Equity	1,742	1,862	1,692	1,560	1,463	785.87
Total Debt	140	73.08	1	-	27.05	-
Net Cash (Debt)	264.38	583.25	480.17	399.68	375.34	199.41
Net Cash Growth	-1.84%	21.47%	20.14%	6.49%	88.22%	10.97%
Net Cash Per Share	1.95	4.27	3.59	2.95	3.40	1.98
Filing Date Shares Outstanding	135.2	135.2	135.2	137.79	135.2	101.4
Total Common Shares Outstanding	135.2	135.2	135.2	137.79	135.2	101.4
Working Capital	600.46	480.45	610.89	818.69	755.71	295.43
Book Value Per Share	8.49	8.32	8.24	7.88	7.15	4.43
Tangible Book Value	1,031	1,006	1,031	1,074	959.25	441.42
Tangible Book Value Per Share	7.62	7.44	7.63	7.79	7.10	4.35
Buildings	156.37	155.85	70.81	68.09	62.58	56.78
Machinery	205.91	201.85	151.47	146.71	101.66	76.73
Construction In Progress	417.56	364.64	325.93	44.37	11.93	10.93

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.